September 12, 2019 – IBA Dosimetry GmbH announced the launch of the new enhanced myQA Machines 2019 software environment at the upcoming American Society for Radiation Oncology (ASTRO) congress, Sept. 15-19 in Chicago.
The latest version of the myQA Machines software enables significantly faster execution of all key linear accelerator (linac) quality assurance (QA) tests. It also allows machine QA tests to be performed independently of the linac systems that are being verified.
The new myQA Machines has been designed to ensure QA efficiency through close integration with the treatment machines while maintaining independence from the machines to be tested, to provide the most reliable quality assurance performance.
To enhance workflow efficiency, each of the linac-specific tests of myQA Machines — like the multileaf collimator (MLC) and volumetric modulated arc therapy (VMAT) checks, as well as the 2-D and 3-D imaging QA tests — can now be measured and analyzed easily in a single workflow that is integrated in one dedicated software interface. Test automation further contributes to QA efficiency and avoids human subjectivity during test analysis.
For more information: www.iba-worldwide.com
April 10, 2026 
